This guide provides a road map for university prevention professionals to collaborate with a wide range of stakeholders, from students to administrators, to address campus-wide drug misuse issues. We use the Strategic Prevention Framework (SPF) here as the “how to” for systematically measuring the scope of drug misuse issues, building relationships with key stakeholders, and planning and implementing a drug misuse prevention effort. Developed by the Substance Abuse and Mental Health Services Administration in 2004, the SPF is evidence based, widely used, and easily adaptable for multiple health issues.
This guide discusses effective prevention practices to mitigate risk factors associated with substance misuse and promote protective factors among: all young adults generally; young adults at significantly higher risk for substance misuse; and young adults who are not diagnosed with a SUD but are engaging in substance misuse.
This guide supports health care providers, systems, and communities seeking to prevent marijuana use by pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
The Central East PTTC recently released A Prevention Guide to Improving Cultural Competency: A Literature Review, intended to support substance use prevention stakeholders in improving their cultural competency and capacity to serve minority and vulnerable populations.
Readers will learn about:
- Resources and recommendations from the Substance Abuse and Mental Health Services Administration (SAMHSA) to improve outreach and communication with minority and vulnerable populations
- The impact cultural competence can have on reducing behavioral health disparities among minority and vulnerable populations
- Evidence-based strategies and conceptual frameworks for implementing organizational change to improve cultural competence
While preliminary data appears to indicate a small decrease in overall drug-related deaths in Florida, Fentanyl-related deaths increased by 164 percent. New strategies may be needed to combat the negative impacts of substances like Fentanyl, especially in the counties that have been affected the most by this epidemic.
By National Action Alliance for Suicide Prevention
The report, designed to build on the Action Alliance’s prior work, presents feasible, evidence-based practices that health systems and providers can take to improve patient engagement and safety during the transition from inpatient to outpatient care. This report aims to help improve and strengthen patient care and ensure that people at risk for suicide receive high-quality, evidence-based, continuous care that supports connection and recovery—and ultimately saves lives.
This report provides a brief update to the 2019 Annual Report of the same name published in April 2019. The update is based on data released since the dissemination of the report that includes national data from the National Survey on Drug Use and Health (NSDUH), sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), and data from the 2018 interim report, Drugs Identified in Deceased Persons by Florida Medical Examiners, prepared by the Florida Medical Examiners Commission, Florida Department of Law Enforcement and published July 2019. (11/15/19)
The 2019 Florida Youth Substance Abuse Survey (FYSAS) Report provides information, data and trends to help guide Florida’s efforts to reduce and prevent the use of alcohol, tobacco and other drugs by school-aged youth. A collaborative effort of the Florida Departments of Children and Families, Health, Education and Juvenile Justice, the 2019 FYSAS was administered to nearly 10,000 middle and high school students from 170 schools across Florida. In its 19th year, the FYSAS provides a valuable source of information for substance use prevention and treatment planning to support Florida’s families and communities. (11/13/19)
This Healthcare Cost and Utilization Project (HCUP) Statistical Brief presents statistics from the 2016 National Inpatient Sample (NIS) on delivery-related inpatient stays involving SUDs, overall and for select types of substances: opioids, cocaine, and other stimulants, as well as for both urban and rural areas. The definition of any substance use does not include tobacco use. Clinical outcomes at delivery are examined and compared across deliveries with and without an SUD diagnosis and by urban or rural location of the patient's residence. (11/13/19)
What is CBD? Is CBD legal? If you have some questions about CBDs, this factsheet provides short, research-based answers to the most common questions based on current knowledge. (10/24/19)
This resource guide for parents offers advice on keeping children substance free. Review statistics about adolescent substance use, and learn tips on good communication. The guide also features substance facts and case studies for additional insight. (10/1/19)
Methamphetamine (meth) is a powerful, highly addictive drug that causes devastating health effects, and sometimes death, even on the first try. (9/23/19)
This Advisory can help clinicians who work in a mental health facility implement a tobacco cessation program to reduce the use of tobacco-related products and tobacco-related diseases among clients with SMI. (9/18/19)
This Advisory highlights how mental and substance use disorder treatment programs can better serve people with physical and cognitive disabilities and substance use disorders (SUDs) and/or serious mental illness (SMI).
The most current prevalence data (2016), indicates that an estimated 61.4 million noninstitutionalized U.S. adults had one or more disabilities.1 SMI and co-occurring substance use disorder SUDs are generally considered disabilities under federal disability rights laws. This publication is not intended to provide guidance on complying with federal, state, or local disability rights laws. This advisory includes some recommendations that are required, may be required or may exceed the requirements of the federal, state, or local disability rights laws. (9/18/19)
Deaths involving synthetic opioids in the United States increased from roughly 3,000 in 2013 to more than 30,000 in 2018. In fact, synthetic opioids like fentanyl are now involved in twice as many deaths as heroin. This book offers a systematic assessment of the past, present, and possible futures of synthetic opioids in the United States. (9/11/19)
I, Surgeon General VADM Jerome Adams, am emphasizing the importance of protecting our Nation from the health risks of marijuana use in adolescence and during pregnancy. Recent increases in access to marijuana and in its potency, along with misperceptions of safety of marijuana endanger our most precious resource, our nation’s youth.
KNOW THE RISKS. TAKE ACTION. PROTECT OUR FUTURE. (8/30/19)
NSDUH is a comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States. These reports and detailed tables present estimates from the 2018 National Survey on Drug Use and Health (NSDUH).
To view the recorded presentation click here. (8/27/19)
The 2018 Florida State Report on Underage Drinking Prevention and Enforcement, prepared by the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) as required by the Sober Truth on Preventing (STOP) Underage Drinking Act is now available. This report describes 26 evidence-based legal policies for underage drinking prevention (Policy Summaries), summarizes and analyzes data on state prevention and enforcement activities and expenditures, and shows state performance on six underage drinking prevention and treatment measures.
A slide presentation that includes key data from the State Report and comparisons with national data is available here. The presentation is intended to be customized by users to provide information to specific audiences about the importance of addressing underage drinking in Florida. (7/31/19)
In this report, the Council provides an overview of the causes and characteristics of homelessness in
Florida, including extensive data on subpopulations, geographic areas, and trends. In addition, a review of
best practices is offered. Finally, based on the data, trends, and best practices, the Council provides specific
recommendations for the State’s consideration. (7/18/19)
Marijuana is the most commonly used illegal substance in the U.S. and its use is growing. Marijuana use among all adult age groups, both sexes, and pregnant women is going up. At the same time, the perception of how harmful marijuana use can be is declining. Increasingly, young people today do not consider marijuana use a risky behavior. (6/20/19)
Data shows that electronic cigarette use among adolescents in Florida is an emerging epidemic. Within two years the E-Cigarette usage has grown 43% among the 11-18-year-old age group. Also, gender difference has been noted with a 61% increase among the girls. (6/14/19)
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. (6/14/19)
The NVDRS collected data from 32 states which reflected that mental health was a major factor in suicide. It also showed that alcohol or other substance use was involved in 29% of those suicides. Suicide is one of the top leading deaths in America. It is also considered to be one of the most common manner of violent deaths. (5/17/19)
There are noteworthy variances in level and trends of cocaine deaths by Managing Entity Regions. These between-region differences suggest the need to strengthen community-based prevention and treatment efforts to curb cocaine use as well as opioid use. While there is increased attention on confronting the Opioid Crisis, cocaine is still the second most powerful addictive stimulant Schedule II drug and the need to prevent and treat its use in Florida continues. (5/17/19)
According to data from diverse resources, the use of synthetic opioids pose a significant public health threat in the United States, with fentanyl and fentanyl analogs in particular. Florida data show a rapidly growing number of deaths are caused by synthetic opioid overdose involving these two opioids in our state. (5/16/19)
It is essential that individuals working with families consider the diversity of families and diverse family structures and situations. The attached resource guide, Meeting the Needs of ALL Families, was compiled by the Family-Run Executive Director Leadership Association (FREDLA)
to highlight the rich diversity and unique needs of today’s families. The resource was developed in recognition of National Children’s Mental Health Awareness Month in May.
This guide is intended to serve as a resource for families and providers to access information that may be particularly relevant for supporting a family. Meeting the Needs of ALL Families is designed to remind all of us that each family is unique, leaving its members to be the only ones to define it – in their way, from their culture and through their truth. (4/30/19)
Vaping poses a considerable – and avoidable – health risk to young people. While waiting for better data on the long-term effects of “vaping” and additional regulations, it is prudent to seek paths to prevent use, especially among teens. According to The 2016 Surgeon General Report, increases in electronic cigarette use, particularly among adolescents, indicates an emerging epidemic despite significant declines in tobacco use. More than 500 brands and flavors of electronic vaping products are currently marketed while the FDA funds research in collaboration with the National Institute of Health to identify evidence-based regulations for these products. (4/24/19)
Based on data from the 2006-2017 National Survey on Drug Use and Health, the reported marijuana use in the past 30 days among Florida adolescents (aged 12-17) increased from 6.8% in 2014-15 to 7.5% in 2016-17 while the national rate declined from 7.4% to 6.4% during the same time period. According to the CDC, National Institute on Drug Abuse, and the American Academy of Child & Adolescent Psychiatry, marijuana use among adolescents can result in learning, emotional and health problems. (4/23/19)
This report provides a statewide and regional overview of substance abuse issues and trends in Florida using information from multiple sources available as of December 2018. It includes information about the progress of the opioid epidemic in Florida, describes historic declines in alcohol use, binge drinking and cigarette smoking among Florida’s middle and high school students and trends in the use of cocaine and Novel Psychoactive Substances. (4/9/19)
This resource is designed to help schools better support students and families in the aftermath of violence and trauma. It provides strategies to assist schools with readiness, response, and recovery to help a school community support resilience in the event of a tragedy. It offers places to turn for more resources and discusses terminology and concepts related to suicide and grief. Finally, it highlights the importance of providing culturally responsive services, with examples of cultural considerations for schools to help Hispanic/Latino students struggling with grief and trauma. (4/9/19)
Prevention of underage drinking represents one of
the priorities of the Florida Department of Children
and Families Office of Substance Abuse and Mental
Health (SAMH). Prevention of initiation represents a
best and most efficient strategy to reduce alcohol
use among adolescents. An increase in initiation
signals a subsequent increase in underage drinking. (3/29/19)
Electronic Nicotine Delivery Systems: Juuling, Other Trends, and Community Prevention. This Practical Theorist is part of a series of publications designed to summarize field research on key drug abuse issues, and to present it in a concise, practical format, with strategies for using the data to mobilize communities and support the mission of coalitions. The publication covers important topics related to electronic nicotine delivery systems (ENDS) including:
- Federal Regulations Impacting the sale of ENDS
- Individual and Environmental factors related to ENDS Use
- Strategies for Prevention and Intervention (2/21/19)
This report provides updated estimates of mental health and substance use disorder spending by payment source and provider, setting, and payer and specialty type. The report highlights spending on behavioral health by private insurers, Medicaid, and Medicare, as well as other payers. Inventory#: SMA19-5095. (2/21/19)
The White House Office of National Drug Control Policy (ONDCP), led by Director Jim Carroll, released its National Drug Control Strategy. The Strategy is intended to guide federal efforts with three overarching categories:
1) preventing illicit drug use through education and evidence-based prevention programs;
2) reducing barriers to treatment services so that access to long-term recovery is available for those suffering from substance use disorder; and
3) reducing the availability of drugs in the United States through law enforcement and cooperation with international partners. (2/11/19)
Despite evidence that maternal depression is common and can impede the development of young children, it is often undiagnosed and untreated. Medicaid can play a leading role in identifying at-risk mothers and connecting them to treatment. NASHP’s new fact sheet provides background on maternal depression while also presenting a summary of state Medicaid policies for screening for maternal depression in the context of well-child visits. (1/31/19)
The report discusses Medicaid coverage of FDA-approved medications for treatment of alcohol and opioid use disorders, limitations on coverage (such as prior authorization requirements), background on federal laws and policies and innovative practices and policies at the state level. (1/4/19)
The Statewide Drug Policy Advisory Council presents its 2018 Annual Report which is a compilation of information from the members of the Council. (1/3/19)
These NIATx fact sheets provide easy access to information on using FDA-approved medications as part of a comprehensive treatment plan for substance use disorders.
This brief describes four key challenges related to the use of medication-assisted treatment (MAT) in child welfare contexts for parents with opioid use disorder. (DHHS, 11/18)
An annual data brief (No. 328, 11/18) published by the CDC’s National Center for Health Statistics presents U.S. mortality data on death rates showing that life expectancy at birth decreased in 2017, largely because of increases in mortality from unintentional injuries, suicide, diabetes, and influenza and pneumonia. (12/4/18)
New collateral print material (below) is incorporated into the Florida Department of Children and Families Overdose Prevention Program educating the public about helping people at risk of experiencing an overdose.
Print #1 - Print #2 - Print #3
The Drug Enforcement Administration has recently published the results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs.
SAMHSA has released 3 new tobacco cessation publications for providers and clients, geared specifically towards substance use disorder treatment settings.
At the Medicare Part D Conference, CMS updated participants regarding their Opioid Overutlilization Strategies in compliance with the Comprehensive Addiction and Recovery Act.
The Medicare Part D Opioid Prescribing Mapping Tool is an online interactive mapping tool that presents geographic comparisons of the opioid prescribing rate at the state, county, and ZIP code levels. The mapping tool presents data for 2016 as well as changes in rates from 2013 to 2016.
Shifts in language, prevalence data, and a digital postcard are some of the resources available through this new report, published through the U.S. Department of Health and Human Services. (9/18)
The 2018 Florida Youth Substance Abuse Survey was just released. In its 19th year, four state agencies – the Departments of Children and Families, Health, Education, and Juvenile Justice - collaborate to administer and provide information to help reduce and prevent the use of alcohol, tobacco and other drugs by school-aged youth. The report includes drug use prevalence rates, valuable prevention planning data and an analysis of risk and protective factors among students.
The Philadelphia Department of Behavioral Health and Intellectual disAbility Services's toolkit is designed to support behavioral health treatment agencies with the process of integrating peer providers into their service settings.
Synthetic cannabinoids are part of the illicit drug category called novel psychoactive substances. NPS are often unregulated and are designed to enter a gray area of the market. The Organized Crime Drug Enforcement Task Force in the Department of Justice, the Centers for Disease Control and Prevention, and NMS Labs of Philadelphia are analyzing, identifying, and characterizing drug samples intercepted upon entry into the United States. (FADAA Substance Abuse Trends Alert, July 2018)
Cigarette Alternatives and Florida’s Youth examines current studies related to tobacco use among Florida’s youth. Statistics related to alternate methods of consuming nicotine are explored and education resources are included. (FADAA Substance Abuse Trends Alert, July 2018)
This report provides a brief statewide and regional update of the substance abuse issues and trends in Florida most recently addressed in the 2018 Annual Report, Patterns and Trends of Substance Use Within and Across the Regions of Florida. This update is based on information from multiple new sources available as of May 2018. (June 2018)
Published by the Office of Mental Health and Suicide Prevention, this report expands on prior analysis of Veteran suicide and examines mortality records, assessing characteristics and rates of suicide. (June 2018)
There are emerging concerns related to the illicit use of stimulants, including data about the growing harm from the abuse of stimulant drugs in Florida and the nation (FADAA Substance Abuse Trends Alert, June 2018)
Updated in June, the SAMHSA Opioid Overdose Prevention Toolkit offers information and facts from literature and links to resources to prevent opioid-related overdoses and deaths. Because interdisciplinary collaboration is critical to success, SAMHSA offers the Toolkit as an educational resource for community members, first responders, prescribers, patients, and families.
Education plays a critical role in preventing substance abuse. Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts. (May 2018)
Popular media often portrays illicit drug use as a problem disproportionately affecting metropolitan communities. However, research and data trends do not support that portrayal. While rural and non-rural communities may face unique challenges when it comes to illicit drug use, data indicates that opioid use prevalence rates are comparable.(FADAA Substance Abuse Trends Alert, April 18)
This report provides a statewide and regional overview of substance abuse issues and trends in Florida using information from multiple sources available as of December 2017. It includes information about the progress of the opioid epidemic in Florida, describes historic declines in alcohol use, binge drinking and cigarette smoking among Florida’s middle and high school students and trends in the use of cocaine and Novel Psychoactive Substances. (May 2018)
SAMHSA's new Resource Center contains a collection of science-based resources for a broad range of audiences, including Treatment Improvement Protocols, toolkits, resource guides, and clinical practice guidelines. Recognizing the enormity of the opioid epidemic, the Resource Center includes an opioid-specific resources section.
Sterling Gildersleeve, Director, presents some important steps Phoenix Recovery Support Services in Chicago, Illinois is taking to prevent opioid overdose among its residents.
Heartland Center for Systems Change Senior Director, Valery Shuman, underscores the importance of examining our misconceptions about people with substance use disorders.
The Chicago Recovery Alliance’s Director, Dan Bigg, explores the role of harm reduction in helping people with substance use disorders stay healthy.
Dr. Alexander Walley highlights the importance of working with active drug users to develop a concrete and realistic plan for how to prevent opioid overdose.
Recent International Actions to Control Deadly Fentanyl Analogs (FADAA Substance Abuse Trends Alert, 1/18)
International cooperation has led to new approaches designed to staunch the flow of fentanyl analogs into the United States.
Opioids and Cocaine: Rapidly Evolving Epidemics in Florida (FADAA Substance Abuse Trends Alert, 12/17)
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants.
Developed by the Yale Program for Recovery and Community Health, this kit helps clients prepare for their first recovery planning meeting and was shared by Dr. Tondora as part of her 1/26/18 Strengths-Based Assessments and Person-Centered Treatment Planning.
SAMHSA has just published The Rx Pain Medications, a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management.
The Florida Department of Health’s factfinding workgroup met to consider strategies health care boards might employ to reduce opioid deaths in Florida.
Hospital stays involving hepatitis C increased 67 percent among Baby Boomer patients more than any other age group, according to a new AHRQ brief. Hospital stays involving hepatitis C nearly tripled likely due to increased needle use associated with the nation's opioid epidemic. Access the brief and visit Webinars to see our latest training on Infectious Disease Control for Persons Who Inject Drugs with Dr. Cook.
More than 1.6 Million Americans Could Die from Drugs, Alcohol and Suicide During Next Decade – A 60 Percent Increase from Previous 10 Years – according to a new report.
This report illustrates how improving community conditions can reduce the incidence and intensity of mental health challenges, and help activate resilience.
The Medical Examiners Commission recently produced their annual report that identifies drugs found in deceased persons investigated by Florida Medical Examiners. The data distinguishes between drugs indicated as the cause of death and other drugs that were present in the body at the time of death. Data was collected on Opioids, Benzodiazepines, and other drug categories.
The final report of the President’s Commission, published 11/2017.
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System.
A collaborative effort between government entities, the 2017 Florida Youth Substance Abuse Survey was just released and assesses risk and protective factors among students. (8/20/18)
This publication provides guidance to clinicians who treat women that are pregnant or of childbearing age with substance use problems. Developed by the University of South Florida, Florida Medicaid Drug Therapy Management Program, and sponsored by the Florida Agency for Health Care Administration, the recommendations also address use of long-acting contraceptives in women of childbearing age
The drug-by-drug review of trends, progress, and challenges addresses: underage drinking; nicotine and E-cigarettes; vaping; marijuana; novel psychoactive substances such as synthetic cannabinoids, synthetic cathinones, tryptamines, and piperazines; cocaine; methamphetamine; heroin; non-medical misuse and abuse of medications such as prescription opioids, benzodiazepines, stimulants, and over the counter (OTC) medications. (June 2017)
This drug-by-drug review of trends, progress, and challenges addresses the astonishing proliferation of substance abuse among Florida youth and adults. (December 2016)